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Open access under the ElMitochondrial dysfunction plays a pivotal role in the cell toxicology and death decision. The aim of the
present study was to investigate the effect of three organocompounds (ebselen [Ebs], diphenyl diselenide
[(PhSe)2] and diphenyl ditelluride [(PhTe)2]) on mitochondrial complexes (I, II, I–III, II–III and IV) activity
from rat liver and kidney to determine their potential role as molecular targets of organochalcogens. All
studied organochalcogens caused a statistically signiﬁcant inhibition of the mitochondrial complex I
activity. Ebs and (PhTe)2 caused a statistically signiﬁcant inhibition of the mitochondrial complex II activ-
ity in both hepatic and renal membranes. Hepatic mitochondrial complex II activity was practically
unchanged by (PhSe)2, whereas it signiﬁcantly inhibited renal complex II activity. Mitochondrial complex
IV activity was practically unchanged by the organochalcogens. Furthermore, organochalcogens inhibited
the mitochondrial respiration supported by complex I or complex II substrates. The inhibitory effect of
Ebs, (PhSe)2 and (PhTe)2 on mitochondrial complex I was prevented by NADH, but it was not prevented
by catalase (CAT) and/or superoxide dismutase (SOD). Additionally, the organochalcogens-induced inhi-
bition of complex I and II was completely reversed by reduced glutathione (GSH). In conclusion, Ebs,
(PhSe)2 and (PhTe)2 were more effective inhibitors of renal and hepatic mitochondrial complex I than
complex II, whereas complexes III and IV were little modiﬁed by these compounds. Taking into account
the presented results, we suggest that organochalcogen-induced mitochondrial complexes I and II inhi-
bition can be mediated by their thiol oxidation activity, i.e., Ebs, (PhSe)2 and (PhTe)2 can oxidize critical
thiol groups from mitochondrial complexes I and II. So, mitochondrial dysfunction can be considered an
important factor in the toxicity of Ebs, (PhSe)2 and (PhTe)2.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Living organisms use a series of integral membrane protein
complexes for energy conversion and ATP synthesis (Hateﬁ,
1985). In addition to their crucial role in energy production and
metabolic pathways, the mitochondrial complexes also play key
roles in integrating cell death stimuli and executing the apoptotic
program (Navarro and Boveris, 2007). Accordingly, several human
diseases, such as Alzheimer’s disease, Friedreich’s ataxia, familial
amyotrophic lateral sclerosis, and Huntington’s disease, are associ-
ated with mitochondrial electron transport chain inhibition, en-
ergy metabolism impairment and oxidative stress (Beal, 1998;
Nicholls and Budd, 2000). Additionally, biochemical studies indi-
cate a decline of electron transport and in some bioenergetic activ-Puntel), +55 3220 8140 (J.B.T.
.L. Puntel), danielvarzeano@
om (R.L. Seeger), jbtrocha@
sevier OA license.ities of mitochondria during aging and ischemia–reperfusion
(Cadenas and Davies, 2000; Caspersen et al., 2005; Cortopassi
and Wong, 1999; Hagen et al., 1998; Hauptmann et al., 2006;
Navarro and Boveris, 2007; Nicholls, 2002; Saris and Eriksson,
1995; Sastre et al., 2003). Thus, mitochondrial dysfunction can be
associated with different degenerative cellular processes.
Organoselenium and organotellurium compounds have been
extensively studied because of their potential antioxidant capacity
(Arteel and Sies, 2001; Barbosa et al., 2006, 2008; de Bem et al.,
2009; de Freitas et al., 2009; Hort et al., 2011; Moretto et al., 2007;
Nogueira and Rocha, 2011; Parnham and Graf, 1991; Prauchner
et al., 2011; Prigol et al., 2008; Puntel et al., 2007). In line with this,
literature data have indicated that these compounds can provide
protective effect against lipid peroxidation induced by a variety of
pro-oxidants agents (Barbosa et al., 2006, 2008; Moretto et al.,
2007; Nogueira and Rocha, 2010, 2011; Parnham and Graf, 1991;
Puntel et al., 2007; Rossato et al., 2002). The antioxidant activity of
these organochalcogens has been ascribed either to their glutathi-
one peroxidase-like activity (Maiorino et al., 1988; Santos et al.,
2005; Sies, 1993, 1995) or to the fact that they can be substrates
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Sausen de Freitas et al., 2010; Zhao and Holmgren, 2002; Zhao
et al., 2002). Thus, in order to exert antioxidant properties, the
selenium containing compounds have to be metabolized to
selenol/selenolate intermediates, a reaction which can be accom-
plished via reduction of the Se moiety by different types of thiols
(Nogueira and Rocha, 2011; Wendel et al., 1984) (Scheme 1). For
organotellurium compounds, it has been postulated that the antiox-
idant activity is linked to changes in the oxidation state of the Te
atom (Te(II)M Te(IV)) (Engman et al., 1995; Leonard et al., 1996;
You et al., 2003).
Thus, the thiol-peroxidase or thioredoxin-thiol-peroxidase-like
activity of organochalcogens (Nogueira and Rocha, 2011; Sausen
de Freitas et al., 2010; Zhao and Holmgren, 2002; Zhao et al.,
2002) can be of biological and therapeutic signiﬁcance via artiﬁcial
modulation of the cellular levels of peroxides. However, the exces-
sive oxidation of thiols, including those in mitochondrial mem-
branes, by organochalcogens without a concomitant reduction of
peroxides may be toxic to living cells (thiol-oxidation activity)
(Nogueira and Rocha, 2011; Puntel et al., 2010) (Scheme 1). In
effect, mitochondrial dysfunction caused by thiol oxidation is clo-
sely related to the apoptotic cell death (Morin et al., 2003; Zhao
et al., 2006). Accordingly, the organochalcogens should be consid-
ered as putative candidates for apoptotic cell death inducer via
mitochondrial dysfunction, which may explain, at least in part,
their pharmacological/toxicological action (Ardais et al., 2010;
Nogueira and Rocha, 2010; Santos et al., 2009a,b). In line with this,
recently our group showed that both Ebselen (Ebs) and diphenyl
diselenide [(PhSe)2] induced mitochondrial dysfunction via inter-
action with critical mitochondria thiols (Puntel et al., 2010).
Considering that mitochondrial complexes play a central role in
cellular metabolism and in the regulation of apoptotic cell death,
we sought to determine whether these mitochondrial complexes
could be considered molecular targets for the thiol-oxidation activ-
ity of Ebs, (PhSe)2 or diphenyl ditelluride [(PhTe)2]. Speciﬁcally, ourScheme 1. Thiol peroxidation and thiol oxidation cycle of dichalcogenides. In the
toxic pathway the formation of the selenol/tellurol is associated with a futile
oxidation of low-molecular- (RSH) or protein-thiol groups (PSH) causing depletion
of GSH levels and/or protein loss of function. In the therapeutic pathway
organochalcogens decompose peroxides either as a substrate for TrxR or as a
mimic of GPx via the formation of the selenol/selenolate or tellurol/tellurate (PhXH/
PhX-) intermediate (X can be Se or Te).main objective in this study was to determine whether Ebs, (PhSe)2
and (PhTe)2 could cause mitochondrial complex(es) I, II, I–III, II–III
and IV inhibition using mitochondrial membranes prepared from
rat liver and kidney. We also determined whether organochalco-
gens could cause mitochondrial respiration inhibition using intact
mitochondria in order to better understand their toxicological site
of action at the molecular level.2. Materials and methods
2.1. Chemicals
Chemicals, including NADH, mannitol, rotenone, succinic acid,
malonate, potassium cyanide (KCN), sucrose, HEPES and cyto-
chrome c were obtained from Sigma Chemical Company (St Louis,
MO, USA). All other reagents were commercial products of the
highest purity grade available.
2.2. Animals
Adult male Wistar rats (250–350 g) from our own breeding col-
ony were used in this study. The animals were housed in plastic
cages with water and food ad libitum, at 22–23 C, 56% humidity,
and 12 h light cycle. The diet of the rats containing (in g/100 g):
52 carbohydrate, 20 crude protein, 5 fat, 6 crude ﬁber, 5 minerals
and 11 moisture. Diet contained 0.1 mg/kg of Se and 30 IU/kg of
vitamin E (for complete mineral and vitamin contents, see refer-
ence (Puntel et al., 2010)). The protocol was approved by the Insti-
tutional Animal Care and Use Committee of Federal University of
de Santa Maria (42/2010) and conducted in accordance with the
Guide for the Care and Use of Laboratory Animals.
2.3. Isolation of rat liver and kidney mitochondria and mitochondrial
membranes preparation
Liver and kidney mitochondria were isolated in a solution con-
taining 0.23 M mannitol, 0.07 M sucrose, 15 mM HEPES (pH 7.2) at
a ratio of 1 g of tissue/9 mL of homogenization medium in a Potter
homogenizer with a Teﬂon pestle. The homogenate was centri-
fuged at 700g for 10 min, and the supernatant centrifuged at
8000g for 10 min to yield a mitochondria pellet that was washed
once in the same buffer. Mitochondrial protein concentration
was adjusted to 20 mg/mL (Peterson, 1977) and the samples were
immediately frozen and kept at 80 C. Mitochondria were dis-
rupted and homogenized by twice freezing and thawing and by
passage through 15/10 tuberculin needles to produce the mito-
chondrial membrane preparation according to (Navarro et al.,
2002) which were used to the mitochondrial complexes activity
assay. In order to study the organochalcogens effect on mitochon-
drial respiration (oxygen consumption measurements) intact mito-
chondria were used.
2.4. Mitochondrial complexes activities assay
The activities of complexes I, I–III, II, II–III, and IV were deter-
mined spectrophotometrically at 30 C with mitochondrial mem-
branes (0.5 mg/mL) suspended in 100 mM phosphate buffer (pH
7.4) as previously described (Navarro et al., 2002, 2004) with minor
modiﬁcations. The mitochondrial membranes were pre-incubated
in phosphate buffer in the presence of different organochalcogens
concentration (Ebs 0–50 lM; [(PhSe)2] 0–100 lM; [(PhTe)2] 0–
100 lM, vehicle (DMSO), or the respective classical inhibitor (posi-
tive controls) for 10 min. After pre-incubation, the reaction was
started with the addition of the corresponding substrate, except
for the experiments using reduced glutathione (GSH), as described
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independently at least 3–5 times (each series of experiment was
performed in duplicate) by use of different biological samples
(samples obtained from different animals).
For NADH:ubiquinone oxidoreductase (complex I) activity as-
say, mitochondrial membranes (0.5 mg/mL) in 100 mM phosphate
buffer, were incubated with different organocompounds or rote-
none (100 lM) for 10 min. The reaction was started after 10 min
by adding NADH to a ﬁnal concentration of 100 lM. The enzymatic
activity was determined, either in the absence or presence of
superoxide dismutase (SOD; 100 UI/mL) and/or catalase (CAT;
100 UI/mL), following the decrease in absorbance at 340 nm during
180 s. In order to study the efﬁcacy of GSH to reverse the organoch-
alcogens-induced complex I inhibition, the mitochondrial mem-
branes were pre-incubated in phosphate buffer in the presence of
organochalcogens (Ebs 25 lM; [(PhSe)2] 50 lM; [(PhTe)2] 50 lM
for 10 min in the absence of GSH. Thereafter the membranes were
washed in phosphate buffer and centrifuged at 12,000g for 10 min
at 4 C to remove the organochalcogens. Then, the membranes
were incubated 5 min with GSH (500 lM; to allow the potential
GSH reversion of the organochalcogens-induced inhibition). After-
ward the mitochondrial complex I activity was assayed as de-
scribed above by determining NADH oxidation.
For NADH–cytochrome c (complexes I–III) activity assay, we
carried out the experiments using two different conditions. In the
condition 1, mitochondrial membranes were pre-incubated with
200 lM NADH (as substrate), 1 mM KCN and with different
organocompounds or 100 lM rotenone for 10 min (pre-incubation
with organocompounds in the presence of NADH). The reaction
was started after addition of 100 lM cytochrome c3 (oxidized
cytochrome). In the condition 2, mitochondrial membranes were
pre-incubated with 100 lM cytochrome c3 (oxidized cytochrome),
1 mM KCN and with different organocompounds or rotenone pre-
incubated for 10 min (pre-incubation with organocompounds in
the absence of NADH). The reaction was then started by adding
200 lM NADH to the reaction mixture. In both conditions, the
enzymatic activity was determined at 550 nm (e = 19 mM1 cm1)
during 120 s.
For succinate:ubiquinone oxidoreductase (complex II) activity
assay, we carried out the experiments in two different conditions.
In the condition 1, mitochondrial membranes in 100 mM phos-
phate buffer were incubated with succinate 5 mM, different
organocompounds or malonate 8 mM. In the condition 2,
mitochondrial membranes were pre-incubated with different
organocompounds or malonate 8 mM (pre-incubation in the
absence of succinate). After 10 min of pre-incubation, MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; 1 mg/mL;
condition 1) or MTT and succinate (5 mM; condition 2) were added
to reaction medium. The reaction was stopped 3 min after MTT by
adding 1 mL of ethanol and the absorbance was determined at
570 nm. In order to study the efﬁcacy of GSH to reverse the organ-
ochalcogens-induced complex II inhibition, the mitochondrial
membranes were pre-incubated in phosphate buffer in the pres-
ence of organochalcogens (Ebs 25 lM; [(PhSe)2] 50 lM; [(PhTe)2]
50 lM for 10 min (according condition 1) in the absence of GSH.
After, the membranes were washed in phosphate buffer to remove
the organochalcogens. Afterward, centrifugations at 12,000g for
10 min at 4 C, mitochondrial membranes were resuspended in
phosphate buffer. Subsequently, mitochondrial membranes were
incubated with GSH (500 lM during 5 min and the mitochondrial
complex II activity was assayed according to condition 1 described
above (by adding MTT). Mitochondrial complex II activity was as-
sessed by the conversion of the MTT dye to formazan. This assay is
based on the reduction of MTT to formazan by mitochondrial
succinate dehydrogenase (SDH). Because selenol/telurol might
reduce MTT per se, we inactivated the succinate dehydrogenaseby heat (10 min at 100 C) in order to discount the potential non-
enzymatic reduction of MTT.
For succinate–cytochrome c reductase (complexes II–III) activ-
ity assay, mitochondrial membranes (0.5 mg/mL) were supple-
mented with succinate 5 mM as substrate and with 1 mM KCN,
and incubated for 10 min with different organocompounds (incu-
bation with organocompounds in the presence of succinate). The
reaction was started by adding 100 lM cytochrome c3 (oxidized
cytochrome). The enzymatic activity was determined at 550 nm
(e = 19 mM1 cm1) during 120 s.
For cytochrome oxidase (complex IV) activity assay, mitochon-
drial membranes (0.5 mg/mL) were incubated in 100 mM
phosphate buffer for 10 min with different organochalcogens or
10 mM KCN. The reaction was started after reduced cytochrome
c2 100 lM addition, and monitored during 180 s. The rate of cyto-
chrome c2 oxidation was calculated as ﬁrst-order reaction constant
k per milligram protein.
2.5. Oxygen consumption measurements
Oxygen consumption was measured in an oxymeter ﬁtted with
a water-jacket Clark-type electrode (Oxytherm – Hansatech Instru-
ments Ltd.). The intact isolated liver mitochondria (approximately
0.5 mg/mL) were pre incubated during 10 min in the standard res-
piration buffer (100 mM sucrose, 65 mM KCl, 10 mM K+-HEPES
buffer (pH 7.2), 50 lM EGTA, 400 lM MgCl2) either in the absence
or presence of organochalcogens (Ebs 25 lM; (PhSe)2 50 lM;
(PhTe)2 50 lM) in order to mimic the same conditions used to
measured mitochondrial complexes activity. The oxygen consump-
tion measurements were determined in the presence of complex I
(pyruvate/glutamate 2.5 mM each) or complex II (succinate 5 mM)
substrates.
2.6. Synthesis of organochalcogens
(PhSe)2 was synthesized using the method previously described
(Paulmier, 1986), (PhTe)2 according to Petragnani (Petragnani,
1994) and Ebs as described by Engman (Engman, 1989). Solutions
of organochalcogens were prepared freshly in dimethylsulfoxide
(DMSO) and the ﬁnal concentration of DMSO in each tube was 3%.
2.7. Statistical analysis
Data were analyzed by one-way ANOVA followed by Duncan´s
multiple range test when appropriate. The data of Figs. 3(A and
B) and 4(A–C) and the effect of the respective classical inhibitors
(vs. control) were analyzed by Student’s t Test. Linear regression
analysis was performed in order to evaluate the concentration
dependence effect of organochalcogens on mitochondrial com-
plexes. A p < 0.05 value was considered statistically signiﬁcant.3. Results
3.1. Effect of organochalcogens in mitochondrial complex I activity
Statistical analysis indicated that Ebs, (PhSe)2 and (PhTe)2 sig-
niﬁcantly inhibited complex I activity from liver and kidney mito-
chondria (Fig. 1A and B, respectively). The inhibitory effect was
concentration dependent in liver membranes, as revealed by the
linear regression analysis (p < 0.05 for all studied organochalcogens).
Ebs-induced complex I inhibition was statistically signiﬁcant from
5 lM onwards, while both (PhSe)2 and (PhTe)2 caused mitochon-
drial complex I inhibition from 10 lM onwards (Fig. 1A and B).
The IC50 (lM) values for inhibition by organochalcogens of
mitochondrial complex I activity are showed in Table 1. Rotenone
Fig. 1. Effect of organochalcogens on mitochondrial complex I activity. Mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C in a medium containing
100 mM phosphate buffer, pH 7.4, in the presence of indicated concentrations of organochalcogens (Ebs 0–50 M; [(PhSe)2] 0–100 lM; [(PhTe)2] 0–100 lM. Complex I activity
is expressed as % of control (without organochalcogens addition). (A) Liver mitochondria membranes; (B) Kidney mitochondrial membranes. —N— (PhSe)2, —d— (PhTe)2,
—j— Ebs, — + — Rotenone (100 lM). The control values (without organochalcogens) were: liver 100.31 ± 4.27; kidney 100.74 ± 6.51. Data are expressed as means ± SEM from
5 independent experiments carried out in duplicate. ⁄p < 0.05 from respective control by Duncan’s multiple range test. #p < 0.05 from control by t test.
Table 1
IC50 (lM) values for inhibition by organochalcogens of mitochondrial complex(es) activity.
Complex(es) Organochalcogen Tissue
Liver Kidney
Complex I Ebs 14.50 ± 2.03 12.41 ± 1.56
(PhSe)2 31.09 ± 1.97 2.92 ± 0.67
(PhTe)2 44.71 ± 2.38 3.88 ± 0.95
Complexes I–III Ebs 3.03 ± 0.51 26.37 ± 3.17
(PhSe)2 ND ND
(PhTe)2 ND ND
Condition 1 Condition 2 Condition 1 Condition 2
Complex II Ebs 18.50 ± 1.43 28.50 ± 1.94 0.92 ± 0.07 16.70 ± 1.07
(PhSe)2 ND ND 2.12 ± 0.30 ND
(PhTe)2 2.70 ± 0.19 16.01 ± 2.07 0.81 ± 0.03 11.70 ± 0.88
Complexes II–III Ebs 31.01 ± 1.44 2.61 ± 0.42
(PhSe)2 ND 20.08 ± 1.70
(PhTe)2 13.19 ± 1.60 3.93 ± 0.19
Complex IV Ebs ND ND
(PhSe)2 27.43 ± 2.05 ND
(PhTe)2 ND ND
ND: Not determined.
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bition of the mitochondrial complex I activity (Fig. 1A–B).
3.2. Effect of organochalcogens in mitochondrial complexes I–III
activity
Fig. 2 shows that Ebs signiﬁcantly inhibited the complexes I–III
activity from liver mitochondrial membranes from 10 lM on-
wards, with maximal effect at 50 lM (Fig. 2A). The inhibitory effect
of Ebs on renal mitochondrial complexes I–III activity was statisti-
cally evident only at 50 lM (Fig. 2B). (PhSe)2 and (PhTe)2 did not
change the mitochondrial complexes I–III activity from liver
(Fig. 2A) or kidney (Fig. 2B). The IC50 (lM) values for inhibition
by organochalcogens of mitochondrial complexes I–III activity
are showed in Table 1.
In order to better understand the inhibitory effect of different
organochalcogens in mitochondrial complexes I–III activity, we
carried out experiments using two different conditions. In brief,
in the condition 1 the membranes were pre-incubated with the
organocompounds (at different concentrations) in the presence of
NADH and the reaction was started with cytochrome c3. In thecondition 2, the mitochondrial membranes were pre-incubated
with different concentrations of oganocompounds and cytochome
c3, and the reaction was started by NADH.
Under condition 1, Ebs (5 lM) signiﬁcantly inhibited complexes
I–III activity from liver (Fig. 3A), without affecting renal complexes
I–III activity (Fig. 3C). (PhSe)2 and (PhTe)2 did not inhibit the mito-
chondrial complexes I–III activity from liver or kidney (Fig. 3A and
B, respectively). However, under condition 2 Ebs, (PhSe)2 and
(PhTe)2 (5 lM) signiﬁcantly inhibited complexes I–III activity from
liver (Fig. 3A) and kidney membranes (Fig. 3B). Rotenone (100 lM)
caused a signiﬁcant inhibition of the mitochondrial complexes I–III
activity that varied from 30% to 70% (Fig. 3A–B).
Since inhibition of respiratory chain complex I could be at least
in part mediated by reactive oxygen species (including H2O2 and
superoxide), we have investigated the potential protection of anti-
oxidant enzymes on Complex I inhibition by Ebs, (PhSe)2 and
(PhTe)2. Results depicted in Fig. 4 indicate that complex I inhibition
by Ebs, (PhSe)2 and (PhTe)2 was not modiﬁed by the addition of
SOD (Fig. 4A), CAT (Fig. 4B) or SOD + CAT (Fig. 4C).
In order to test the hypothesis that organochalcogens-induced
complex I inhibition is mediated by oxidation of thiol groups, we
Fig. 2. Effect of organochalcogens on mitochondrial complexes I–III activity. The mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C in a medium
containing 100 mM phosphate buffer, NADH (200 lM), pH 7.4, in the presence of indicated concentrations of organochalcogens. Complexes I–III activity is expressed as % of
control (without organochalcogens addition). (A) Liver mitochondria membranes; (B) kidney mitochondrial membranes. —N— (PhSe)2, —d— (PhTe)2, —j— Ebs. The control
values (without organochalcogens) were: liver 99.94 ± 2.21; kidney 101.03 ± 3.12. Data are expressed as means ± SEM from ﬁve independent experiments carried out in
duplicate. ⁄p < 0.05 from respective control by Duncan’s multiple range test.
Fig. 3. Effect of organochalcogens on mitochondrial complexes I–II activity under different assay conditions. The mitochondria membranes were incubated (0.5 mg/mL) for
10 min at 30 C in a medium containing 100 mM phosphate buffer, pH 7.4, in the presence of indicated concentrations of organochalcogens with (white bars) or without (gray
bars) NADH (200 lM). Complexes I–III activity is expressed as % of control (without organochalcogens addition). (A) Liver mitochondria membranes; (B) kidney mitochondrial
membranes. Control (absence of organocompounds); (PhSe)2 (5 lM); (PhTe)2 (5 lM); Ebs (5 lM); Rotenone (100 lM). Data are expressed as means ± SEM from 5
independent experiments carried out in duplicate. ⁄p < 0.05 from respective control by t test. #p < 0.05 condition 1 vs condition 2 by t test.
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induced inhibition of complex I. Fig. 5 shows that GSH (500 lM)
completely reversed the organochalcogens-induced complex I
inhibition in hepatic (Fig. 5A) and in renal (Fig. 5B) membranes.
3.3. Effect of organochalcogens in mitochondrial complex II activity
In order to check the inhibitory effect of different organochalcogens
in mitochondria complex II activity, we carried out experiments at
two different conditions. In brief, in condition 1 the membranes
were incubated with the organocompounds (at different concen-
trations) in the presence of succinate 5 mM for 10 min. The reac-
tion was stopped 3 min after MTT by addition of ethanol. In
condition 2, the mitochondrial membranes were incubated with
various concentrations of organocompounds in the absence of suc-
cinate for 10 min. Succinate (5 mM) and MTT were then added and
the reaction stopped after 3 min by the addition of ethanol.
Statistical analysis indicates that Ebs and (PhTe)2 signiﬁcantly
inhibited both hepatic and renal complex II activity in both condi-tions (Fig. 6). In contrast, (PhSe)2 did not change the mitochondrial
complex II activity from liver (Fig. 6A and B), but inhibited renal
complex II activity under condition 1 (Fig. 6C), without inhibiting
it under experimental condition 2 (Fig. 6D). The IC50 (lM) values
for inhibition by organochalcogens of mitochondrial complex II
activity, in both conditions, are showed in Table 1. Malonate
(8 mM) caused a signiﬁcant inhibition of the mitochondrial com-
plex II activity that varied from 40% to 70% inhibition (see
Fig. 6A–D). GSH (500 lM)completely reversed the organochalcogens-
induced complex II inhibition both in hepatic (Fig. 7A) and renal
(Fig. 7B) membranes.
3.4. Effect of organochalcogens in mitochondrial complexes II–III
activity
Ebs and (PhTe)2 inhibited the mitochondrial complexes II–III
activity from liver (Fig. 8A) and kidney (Fig. 8B). (PhSe)2 did not
inhibit hepatic complexes II–III activity (Fig. 8A), but signiﬁcantly
inhibited renal complexes II–III activity (Fig. 8B). The IC50 (lM)
Fig. 4. Effect of SOD and/or CAT on organochalcogens-induced hepatic mitochondrial complex I inhibition. Hepatic mitochondria membranes were incubated (0.5 mg/mL) for
10 min at 30 C in a medium containing 100 mM phosphate buffer, pH 7.4, in the presence of organochalcogens (Ebs 25 lM; [(PhSe)2] 50 lM; [(PhTe)2] 50 lM either in the
absence or presence of SOD (100 UI/mL) (A); CAT (100 UI/mL) (B); SOD + CAT (100 UI/mL each) (C). Complex I activity is expressed as % of control (without organochalcogens
addition). Data are expressed as means ± SEM from ﬁve independent experiments carried out in duplicate. Comparisons among the experiments with vs. without antioxidant
enzymes were done by t test. ⁄p < 0.05 from respective control by Duncan’s multiple range test.
Fig. 5. Reversion by GSH of Ebs-, (PhSe)2-, or PhTe)2-induced mitochondrial complex I inhibition. Mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C in
a medium containing 100 mM phosphate buffer, pH 7.4, in the presence of organochalcogens (Ebs 25 lM; [(PhSe)2] 50 lM; [(PhTe)2] 50 lM. The activity of mitochondrial
complex I was determined after washing by centrifugation (12,000g for 10 min at 4 C) the membranes to remove the organochalcogens and, sequentially, after incubating for
5 min in the presence of GSH (500 lM). (A) Liver mitochondria membranes; (B) kidney mitochondrial membranes. Complex I activity is expressed as % of control (without
organochalcogens addition). Data are expressed as means ± SEM from 3–5 independent experiments carried out in duplicate. ⁄p < 0.05 from respective control by Duncan’s
multiple range test. #p < 0.05 without vs with GSH by t test.
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Fig. 6. Effect of organochalcogens on mitochondrial complex II activity. The mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C in a medium
containing 100 mM phosphate buffer, pH 7.4, in the presence of indicated concentrations organochalcogens of under two different conditions: Condition 1 (with succinate
5 mM); Condition 2 (without succinate). Values of complex II activity are expressed as % of control (without organochalcogens addition). (A) Liver mitochondrial membranes
under condition 1 (Control value 98.50 ± 5.08); (B) liver mitochondrial membranes under condition 2 (Control value 100.09 ± 3.21); (C) kidney mitochondrial membranes
under condition 1 (Control value 102.55 ± 6.98); (D) Kidney mitochondrial membranes under condition 2 (Control value 101.95 ± 5.66). —N— (PhSe)2, —d— (PhTe)2, —j—
Ebs, — + — Malonate (8 mM). Data are expressed as means ± SEM from 5 independent experiments carried out in duplicate. ⁄p < 0.05 from respective control by Duncan’s
multiple range test. #p < 0.05 from control by t test.
R.L. Puntel et al. / Toxicology in Vitro 27 (2013) 59–70 65values for inhibition by organochalcogens of mitochondrial com-
plexes II–III activity are showed in Table 1.
3.5. Effect of organochalcogens in mitochondrial complex IV activity
Statistical analysis revealed that Ebs did not modify the hepatic
(Fig. 9A) or renal (Fig. 9B) complex IV activity. (PhSe)2 slightly
inhibited complex IV activity from liver and kidney (Fig. 9A and
B), whereas (PhTe)2 did not change the renal complex IV activity
(Fig. 9B); but it inhibited hepatic complex IV activity at 50 lM
(Fig. 9A). The IC50 (lM) value for inhibition by (PhSe)2 of mitochon-
drial complex IV activity is showed in Table 1. Potassium cyanide
(KCN, 10 mM) caused a signiﬁcant inhibition of the mitochondrial
complex IV activity that varied from 93% to 100% inhibition (Fig. 9A
and B).
3.6. Effects of organochalcogens in oxygen consumption in intact
mitochondria
Ebs (25 lM), (PhSe)2 (50 lM), and (PhTe)2 (50 lM) inhibited
oxygen consumption in intact liver mitochondria supported eitherby pyruvate/glutamate (complex I substrates; Fig. 10A) or
succinate (complex II substrate; Fig. 10B) as substrates. For mito-
chondrial oxygen consumption, the inhibitory potency order was
Ebs  (PhTe)2 > (PhSe)2, independent of the substrate used. In fact,
Ebs and (PhTe)2 completely inhibits oxygen consumption, whereas
(PhSe)2 was less active. Taking into account, the results obtained
with intact mitochondria are in accordance with our ﬁndings using
mitochondrial membranes (isolated complexes assay).4. Discussion
The results presented here indicate that the hepatic and renal
toxicity of organochalcogens can be, at least in part, mediated by
mitochondrial dysfunction via inhibition of differentmithochondri-
al complexes, which can explain our previous results (Puntel et al.,
2010). Here we found that mitochondrial complex I was the key
complex targeted by the organocompounds (almost 100% inhib-
ited), followed by the complex II, whereas the inhibition of complex
III and complex IV was negligible. Furthermore, both hepatic and
renal mitochondrial preparations seem to be similarly inhibited
by organochalcogens. In fact, despite of different susceptibility of
Fig. 7. Reversion by GSH of Ebs-, (PhSe)2-, or PhTe)2-induced mitochondrial complex II inhibition. Mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C
in a medium containing 100 mM phosphate buffer, pH 7.4, in the presence of organochalcogens (Ebs 25 lM; [(PhSe)2] 50 lM; [(PhTe)2] 50 lM. The activity of mitochondrial
complex II was determined after washing the membranes to remove the organochalcogens and after incubating washed membranes for 5 min in the presence of GSH
(500 lM). (A) Liver mitochondria membranes; (B) kidney mitochondrial membranes. Complex II activity is expressed as % of control (without organochalcogens addition).
Data are expressed as means ± SEM from 3–4 independent experiments carried out in duplicate. ⁄p < 0.05 from respective control by Duncan’s multiple range test. #p < 0.05
without vs with GSH by t test.
Fig. 8. Effect of organochalcogens on mitochondrial complexes II–III activity. The mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C in a medium
containing 100 mM phosphate buffer, pH 7.4, in the presence of indicated concentrations of organochalcogens. Complexes II–III activity is expressed as % of control (without
organochalcogens addition). (A) Liver mitochondria membranes; (B) kidney mitochondrial membranes. —N— (PhSe)2, —d— (PhTe)2, —j— Ebs. The control values (without
organochalcogens) were: liver 99.56 ± 2.50; kidney 101.16 ± 1.12. Data are expressed as means ± SEM from 5 independent experiments carried out in duplicate. ⁄p < 0.05 from
respective control by Duncan’s multiple range test.
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organochalcogens (Nogueira and Rocha, 2010, 2011), isolated
hepatic and renal mitochondria tended to respond similarly to the
inhibitory properties of organochalcogens. Thus we suggest that
the differences in the tissues susceptibility when exposed to organ-
ochalcogens (Nogueira and Rocha, 2010, 2011) can be associated
with other factors, such as differential distribution and metabolism
of organochalcogens in these tissues.
Moreover, here we have used mitochondrial membranes in or-
der to study the direct effect of organochalcogens on the com-
plexes activity to avoid indirect effects of organochalcogen on
complexes via modiﬁcation of mitochondrial functionality (extent
of polarization, presence of additional membrane barriers, etc., for
details see (Puntel et al., 2010)). We know that the amounts or
activities of speciﬁc complexes and enzymes can be useful to testspeciﬁc hypotheses but should generally be held in reserve and
not used as the primary assay for mitochondrial dysfunction
(Brand and Nicholls, 2011). Hence, oxygen consumption data using
intact mitochondria (Fig. 10) validated our ﬁndings with mitochon-
drial membranes and suggested that the inhibition of mitochon-
drial complexes is involved in the reduction of oxygen
consumption by intact mitochondria.
Although there are no compelling data in the literature reporting
the intracellular concentrations of these chalcogenides after acute
or chronic treatment, we have previously observed that exposure
to toxic doses of (PhSe)2 increased selenium deposition in liver to
levels as high as 100 lM (Maciel et al., 2003). Thus, it is reasonable
to suggest that after exposure to high doses, mitochondriamay play
an important role in the toxicity of organochalcogens. Accordingly,
(PhSe)2 have been reported to cause cytotoxicity to a neuronal cell
Fig. 9. Effect of organochalcogens on mitochondrial complex IV activity. The mitochondria membranes were incubated (0.5 mg/mL) for 10 min at 30 C in a medium
containing 100 mM phosphate buffer, pH 7.4, in the presence of indicated concentrations of organochalcogens. Complex IV activity is expressed as % of control (without
organochalcogens addition). (A) Liver mitochondria membranes; (B) kidney mitochondrial membranes. —N— (PhSe)2, —d— (PhTe)2, —j— Ebs, —— KCN (10 mM). The
control values (without organochalcogens) were: liver 101.05 ± 3.05; kidney 99.37 ± 2.03. Data are expressed as means ± SEM from 5 independent experiments carried out in
duplicate. ⁄p < 0.05 from respective control by Duncan’s multiple range test. #p < 0.05 from control by t test.
Fig. 10. Effect of organochalcogens on Hepatic Mitochondrial oxygen consumption. Isolated rat liver mitochondria (0.5 mg/mL) were pre incubated 10 min in the absence or
presence of different orcanochalcogens studied at indicated concentrations and the oxygen consumption was measured as described in the Materials and methods using
Pyruvate/glutamate (2.5 mM each) (A) or succinate (5 mM) (B) as substrates. The arrows indicate sequential additions of: Mit, 0.5 mg/mL mitochondria; Py/Glu, 2.5 mM
pyruvate and 2.5 mM glutamate; Succ, 5 mM succinate; ADP/Pi, 0.3 mM ADP and 0.6 mM inorganic phosphate; Olig, 2 lM oligomycin; and 2,4 DNP, 10 lM dinitrophenol.
—e— Control, —N— (PhSe)2, —d— (PhTe)2, —j— Ebs. Data (oxygen content in the medium) are expressed as means ± SEM from 4 independent experiments carried out in
duplicate. The numbers in the Figures represent the respiratory rate (expressed as rate medium of 4 independent experiments performed in duplicates).
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pathway (Posser et al., 2011). However, literature data about the
cytotoxicity of these compounds are scarce. In fact, Ebs (at 50–
75 lM) was toxic to human hepatoma cells (HepG2) and induced
apoptosis via disruption of mitochondrial physiology that was
dependent on cellular thiol depletion (Yang et al., 2000). The corre-
lation of these concentrations with the concentration of organoch-
alcogens used here in isolated mitochondria is difﬁcult to be done.
However, since authors have exposed HepG2 cells only brieﬂy to
these relatively high concentration of Ebs (50–75 lM), we can sup-
pose that mitochondria exposure to lM concentrations of organ-
ochalcogens is plausible to occur in vitro and after in vivo
exposure to high doses of these agents. However, literature has
not explored the concentrations of organochalcogens that could
be toxic to primary cells and there is no study about their effects
on mitochondria respiration using intact cells and/or tissue slices.
Thus, it is important to emphasize that this is the ﬁrst report con-cerning the inhibitory effect of studied organochalcogens on mito-
chondrial complexes activity.
Taken together, our results indicate that Ebs, (PhSe)2, and
(PhTe)2 inhibit the activity of mitochondrial complexes I and II
from liver and kidney. This inhibition probably involves the inter-
action of these compounds with essential cysteinyl residues of
mitochondrial complexes (represented by PSH in Scheme 1), as
indicated by our data using GSH (see Figs. 5 and 7). In fact, the
mitochondrial complexes (complexes I–IV) are well known to be
oxidatively modiﬁed in physiological and non-physiological condi-
tions, which can culminate with their inhibition (Beltran et al.,
2000; Clementi et al., 1998; Le-Quoc et al., 1981; Navarro and
Boveris, 2007; Navarro et al., 2002, 2004, 2005; Ohnishi et al.,
1998). In line with this, Ebs, (PhSe)2, and (PhTe)2 were reported
to inhibit d-ALA-D (Barbosa et al., 1998; Folmer et al., 2005; Maciel
et al., 2000; Rocha et al., 2012), Na+K+/ATPase (Borges et al., 2005),
and LDH (Lugokenski et al., 2011) by binding to sulfhydryl groups
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pounds studied here inhibited the mitochondrial complexes via
their thiol oxidation activity (Scheme 1).
Our assumption is further supported by the results presented in
Fig. 3(A–B) where we have used different assay conditions. In fact,
we found that incubation of mitochondrial membranes with the
complex I substrate (NADH) partially prevents the inhibitory effect
of chalcogens on complex I activity. Our hypothesis is further sup-
ported by previous data from our laboratory showing that (PhSe)2-
induced LDH inhibition was attenuated or abolished by NADH
(Lugokenski et al., 2011). These data indicate that NADH can mod-
ulate enzyme conformation preventing the critical thiols from the
attack by organochalcogens. Based on the presented results, we
suggest that organochalcogen-induced mitochondrial complex I
inhibition is linked to their interaction with critical thiol groups
present in the active site of the NADH:ubiquinone oxidoreductase
(Lin et al., 2002).
As mentioned above, the complex I inhibition by organochalco-
gens was more pronounced than complex II. We suggest that, de-
spite of succinate dehydrogenase (SDH) being described to
possess sulfhydryl group essential for catalytic activity, located in
the substrate site (Le-Quoc et al., 1981), the organochalcogens-
induced mitochondrial complex II inhibition could be due to their
interaction with other thiols critical to enzyme activity, than that
located in the active site of the SDH (Lin et al., 2002). Our data
are further supported by previous data showing that complex II
is less prone to inactivation than complex I (Cadenas and Davies,
2000; Orrenius et al., 2007; Zhang et al., 1990). Thus, based on
the presented results (Figs. 5 and 7) we suggest that both com-
plexes I and II were directly affected by the organochalogens, being
the thiols groups the molecular site of action for the organochalc-
ogens. Our hypothesis is further supported by the data showing
that organochalcogens induced complex I inhibition was not med-
iated by ROS formation (Figs. 4A–C).
However, as seen in Figs. 6 and 8, (PhSe)2 has differential effect
on complex II in liver and kidney. At the present moment, these re-
sults are not completely understood, but they can be related to dif-
ferences in the molecular composition of mitochondria obtained
from different tissues (Benard et al., 2006). Thus, we speculate that
the liver and kidney could present different contents and isoforms
of complex II enzymes, which resulted in different inhibition by
(PhSe)2. Our assumption is based on previous data showing that,
at least, two different isoforms of complex II have been reported
in the literature (Tomitsuka et al., 2003a,b; Tomitsuka et al., 2009).
In addition to complexes I and II, the activities of the mitochon-
drial complexes III and IV (both fromrat liver andkidney)were prac-
tically not targeted by organocompounds. In fact, mitochondrial
complex III was minimally inhibited by the treatment with studied
compounds, whereas complex IV was nearly unchanged. Thus,
organochalcogens possibly did not inhibitmitochondrial complexes
III and IV due to steric hindrance of their sulfhydryl groups to the
organochalcogens (Lin et al., 2002). Our ﬁndings are supported by
previous report showing that thiol groups from complex IV are less
prone to oxidation than that from complex I (Orrenius et al., 2007).
As pointed previously, damage to the mitochondrial electron
transport chain has been suggested to be an important factor in
the pathogenesis of a range of diseases where the oxidative stress
seems to be involved (Beltran et al., 2000; Clementi et al., 1998;
Dahm et al., 2006; Fattal et al., 2006; Hurd et al., 2007; Le-Quoc
et al., 1981; Madrigal et al., 2001; Navarro and Boveris, 2007;
Navarro et al., 2002, 2004, 2005; Ohnishi et al., 1998; Taylor
et al., 2003). In addition, mitochondrial dysfunction (as evidenced
by decline in respiratory chain activity) is closely linked to both
age and ischemia–reperfusion-associated mitochondrial changes,
that culminates, in some cases, to apoptotic cell death (Cadenas
and Davies, 2000; Caspersen et al., 2005; Hauptmann et al.,2006; Navarro and Boveris, 2007; Nicholls, 2002; Sastre et al.,
2003). Thus, based on the presented results and in the previously
published data (Puntel et al., 2010) it is reasonable to suggest that
mitochondrial dysfunction could be a central process in the hepa-
totoxicity of organochalcogens after in vivo exposure. Kidney could
also be targeted by high doses of organochalcogens; however, the
deposition of these compounds in kidney is less accentuated than
in liver (Maciel et al., 2003).
In conclusion, here we clearly demonstrate that Ebs, (PhSe)2,
and (PhTe)2 – induced mitochondrial complexes inhibition, and
that their effects virtually did not vary among the hepatic and renal
mitochondria. The mitochondrial complex I was the most suscep-
tible to organochalcogens-induced inhibition, followed by complex
II. Based on our data, we believe that inhibitory effect of organoch-
alcogens could be attributed to oxidation of essential thiols in the
enzyme complexes. Taking this into account, we suggest that mito-
chondrial complex I and II could be considered important molecu-
lar targets of organochalcogens after exposure to high dosages of
these compounds.
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